Diagnosis and management of vascular cognitive impairment and dementia

  • T. Erkinjuntti
Conference paper

Summary

Vascular dementias (VaDs) are the second most common cause of dementia. Cerebrovascular disease (CVD) and stroke relates to high risk of cognitive impairment, but also relate to Alzheimer’s disease (AD):

Vascular cognitive impairment (VCI) and dementias extend beyond the traditional multi-infarct dementia. Pathophysiology of VaD incorporates interactions between vascular etiologies (CVD and vascular risk-factors), changes in the brain (infarcts, white matter lesions, atrophy), host factors (age, education) and cognition.

Variation in defining the cognitive syndrome, in vascular etiologies, and allowable brain changes in current criteria have resulted in variable estimates of prevalence, of groups of subjects, and of the types and distribution of putative causal brain lesions.

Should new criteria be developed? Ideally in constructing new criteria the diagnostic elements should be tested with prospective studies with clinical-pathological correlation: replace dogma with data. Meanwhile focus on more homogenous subtypes of VaD, and on imaging criteria could be a solution.

Subcortical ischemic vascular disease and dementia (SIVD) incorporate small vessel disease as the chief vascular etiology, lacunar infarct and ischaemic white matter lesions as primary type of brain lesions, subcortical location as the primary location of lesions, and subcortical syndrome as the primary clinical manifestation. It incorporates two clinical entities “Binswanger’s disease” and “the lacunar state”.

AD with VaD (mixed dementia) has been underestimated as a prevalent cause in the older population. In addition to simple co-existence, VaD and AD have closer interaction: several vascular risk factors and vascular brain changes relate to clinical manifestation of AD, and they share also common pathogenetic mechanisms.

Vascular cognitive impairment (VCI) is a category aiming to replace the “Alzhemerized” dementia concept in the setting of CVD, and substitute it with a spectrum that includes subtle cognitive deficits of vascular origin, poststroke dementia, and the complex group of the vascular dementias.

As far there is no standard treatment for VaDs, and still little is known on the primary prevention (brain at risk for CVD) and secondary prevention (CVD brain at risk for VCI/VaD). There is no standard symptomatic treatment for VaD. Recently symptomatic cholinergic treatment has shown promise in AD with VaD, as well as probable VaD. Future focus should be directed to the distinct etiological and pathological factors: the vascular and the AD burden of the brain.

Keywords

Vascular Dementia Small Vessel Disease Vascular Cognitive Impairment Medial Temporal Lobe Atrophy Mixed Dementia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amar K, Wilcock G (1996) Vascular dementia [Review] [65 refs]. BMJ 312: 227–231Google Scholar
  2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th ed. American Psychiatric Association, Washington, DCGoogle Scholar
  3. Babikian V, Ropper AH (1987) Binswanger’s disease: a review. Stroke 18: 2–12CrossRefPubMedGoogle Scholar
  4. Berchtold NC, Cotman CW (1998) Evolution in the conceptualization of dementia and Alzheimer’s disease: Greco Roman period to the 1960s. Neurobiol Aging 19: 173–189CrossRefPubMedGoogle Scholar
  5. Bowler JV, Hachinski V (1995) Vascular cognitive impairment: a new approach to vascular dementia. [Review] [75 refs]. Baillieres Clin Neurol 4: 357–376PubMedGoogle Scholar
  6. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82: 239–259CrossRefGoogle Scholar
  7. Brun A (1994) Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. Dementia 5: 145–147PubMedGoogle Scholar
  8. Brust JC (1988) Vascular dementia is overdiagnosed [Review] [76 refs]. Arch Neurol 45: 799–801Google Scholar
  9. Chui HC (1989) Dementia: a review emphasizing clinicopathologic correlation nd brainbehavior relationships. Arch Neurol 46: 806–814CrossRefPubMedGoogle Scholar
  10. Chui HC (1998) Rethinking vascular dementia: moving from myth to mechanism. In: Growdon JH, Rossor MN (eds) The dementias. Butterworth-Heinemann, Boston, pp 377–401Google Scholar
  11. Chui HC (2001) Vascular dementia, a new beginning. Shifting focus from clinical phenotype to ischemic brain injury. Neuroloci clinics 18: 951–977CrossRefGoogle Scholar
  12. Chui HC, Gonthier R (1999) Natural history of vascular dementia. Alzheimer Dis Assoc DisordGoogle Scholar
  13. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R (1992) Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers [see comments]. Neurology 42: 473–480CrossRefPubMedGoogle Scholar
  14. Cummings JL (1993) Fronto-subcortical circuits and human behavior. Arch Neurol 50: 873–880CrossRefPubMedGoogle Scholar
  15. Cummings JL (1994) Vascular subcortical dementias: clinical aspects [Review] [25 refs]. Dementia 5:177–180PubMedGoogle Scholar
  16. Desmond DW (1996) Vascular dementia: a construct in evolution [Review] [215 refs]. Cerebrovasc Brain Metab Rev 8: 296–325PubMedGoogle Scholar
  17. Desmond DW, Erkinjuntti T, Sano M et al (1999) The cognitive syndrome of vascular dementia: implications for clinical trials. Alzheimer Dis Assoc DisordGoogle Scholar
  18. Doody RS, Stevens JC, Beck C et al (2001) Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56: 1154–1166CrossRefPubMedGoogle Scholar
  19. Erkinjuntti T (1987a) Differential diagnosis between Alzheimer’s disease and ascular dementia: evaluation of common clinical methods. Acta Neurol Scand 76: 433–442CrossRefPubMedGoogle Scholar
  20. Erkinjuntti T (1987b) Types of multi-infarct dementia. Acta Neurol Scand 75: 391–399CrossRefPubMedGoogle Scholar
  21. Erkinjuntti T (1994) Clinical criteria for vascular dementia: the NINDS-AIREN criteria. Dementia 5: 189–192PubMedGoogle Scholar
  22. Erkinjuntti T (1996) Clinicopathological study of vascular dementia. In: Prohovnik I, Wade J, Knezevic S, Tatemichi TK, Erkinjuntii T (eds) Vascular dementia. Current concepts. John Wiley & Sons, Chichester, pp 73–112Google Scholar
  23. Erkinjuntti T (1997) Vascular dementia: challenge of clinical diagnosis. Int Psychogeriatr 9: 51–58CrossRefPubMedGoogle Scholar
  24. Erkinjunti T (1999) Cerebrovascular dementia: a quide to diagnosis and treatment. CNS DrugsGoogle Scholar
  25. Erkinjuntti T, Hachinski VC (1993) Rethinking vascular dementia. Cerebrovasc Dis 3: 3–23CrossRefGoogle Scholar
  26. Erkinjuntti T, Pantoni L (2002) Subcortical vascular dementia. In: Gauthier S, Cummings JL (eds) Alzheimer’s diasease and related disorders annual. Martin Dunitz, London, pp 101–133Google Scholar
  27. Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A (1988) Accuracy of the clinical diagnosis of vascular dementia: a rospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry 51: 1037–1044CrossRefPubMedGoogle Scholar
  28. Erkinjuntti T, Benavente O, Eliasziw M et al (1996) Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. Arch Neurol 53: 325–332CrossRefPubMedGoogle Scholar
  29. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V (1997a) The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 337: 1667–1674CrossRefPubMedGoogle Scholar
  30. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V (1997b) The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 337: 1667–1674CrossRefPubMedGoogle Scholar
  31. Erkinjuntti T, Bowler JV, DeCarli C et al (1999) Imaging of static brain lesions in vascular dementia: implications for clinical trials. Alzheimer Dis Assoc Disord 13: S81–S90PubMedGoogle Scholar
  32. Erkinjuntti T, Inzitari D, Pantoni L et al (2000) Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm 59: 23–30Google Scholar
  33. Erkinjunti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, ChandrasekharRao VD (2001) Galantamine is efficacious in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease. J Am Ger Soc (in press)Google Scholar
  34. Fischer P, Gatterer G, Marterer A, Simanyi M, Danielczyk W (1990) Course characteristics in the differentiation of dementia of the Alzheimer type and multi-infarct dementia. Acta Psychiatr Scand 81: 551–553CrossRefPubMedGoogle Scholar
  35. Fratiglioni L, Launer LJ, Andersen K et al (2000) Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 54: S10–S15PubMedGoogle Scholar
  36. Gold G, Giannakopoulos P, Montes-Paixao JC et al (1997) Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 49: 690–694CrossRefPubMedGoogle Scholar
  37. Gortelmeyer R, Erbler H (1992) Memantine in treatment of mild to moderate dementia syndrome. Drug Res 42: 904–912Google Scholar
  38. Hachinski VC (1990) The decline and resurgence of vascular dementia [Review] [41 refs]. CMAJ 142:107–111PubMedGoogle Scholar
  39. Hachinski V (1992) Preventable senility: a call for action against the vascular dementias [see comments] [Review] [33 refs]. J Am Ger Soc 340: 645–648Google Scholar
  40. Hachinski VC, Lassen NA, Marshall J (1974) Multi-infarct dementia. A cause of mental deterioration in he elderly. J Am Ger Soc ii: 207–210Google Scholar
  41. Hachinski VC, Iliff LD, Zilhka E et al (1975) Cerebral blood flow in dementia. Arch Neurol 32: 632–637CrossRefPubMedGoogle Scholar
  42. Hebert R, Brayne C (1995) Epidemiology of vascular dementia [Review] [75 refs]. Neuroepidemiology 14: 240–257CrossRefPubMedGoogle Scholar
  43. Inzitari D, Erkinjuntti T, Wallin A, del Ser T, Romanelli M, Pantoni L (2000) Subcortical vascular dementia as a specific target for clinical trials. Ann NY Acad Sci 903: 510–521CrossRefPubMedGoogle Scholar
  44. Ishii N, Nishihara Y, Imamura T (1986) Why do frontal lobe symptoms predominate in vascular dementia with lacunes? Neurology 36: 340–345CrossRefPubMedGoogle Scholar
  45. Kalaria RN, Ballard C (1999) Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 13: S115–S123CrossRefPubMedGoogle Scholar
  46. Knezevic S, Labs KH, Kittner B, Rossner M, Rother M (1996) The treatment of vascular dementia: problems and prospects. In: Prohovnik I, Wade J, Knesevich J, Tatemichi TK, Erkinjunti T (eds) Vascular dementia. Current concepts. John Wiley & Sons, Chichester, pp 301–312Google Scholar
  47. Kokmen E, Whisnant JP, O’Fallon WN, Chu CP, Beard CM (1996) Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960–1984). Neurology 46: 154–159CrossRefPubMedGoogle Scholar
  48. Konno S, Meyer JS, Terayama Y, Margishvili GM, Mortel KF (1997) Classification, diagnosis and treatment of vascular dementia [Review] [83 refs]. Drugs & Aging 11:361–373CrossRefGoogle Scholar
  49. Last JM (1988) A dictionary of epidemiology, 2nd edn. Oxford University Press, New YorkGoogle Scholar
  50. Lechner H (1998) Status of treatment of vascular dementia [Review] [19 refs]. Neuroepidemiology 17: 10–13Google Scholar
  51. Lobo A, Launer LJ, Fratiglioni L et al (2000) Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 54: S4–S9CrossRefPubMedGoogle Scholar
  52. Loeb C, Meyer JS (1996) Vascular dementia: still a debatable entity? [Review] [50 refs]. J Neurol Sci 143: 31–40CrossRefPubMedGoogle Scholar
  53. Loeb C, Gandolfo C, Croce R, Conti M (1992) Dementia associated with lacunar infarction. Stroke 23: 1225–1229CrossRefPubMedGoogle Scholar
  54. Lopez OL, Larumbe MR, Becker JT et al (1994) Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia [see comments]. Neurology 44: 1240–1245CrossRefPubMedGoogle Scholar
  55. Mahler ME, Cummings JL (1991) The behavioural neurology of multi-infarct dementia. Alzheimer Dis Assoc Disord 5:122–130CrossRefPubMedGoogle Scholar
  56. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34: 939–944CrossRefPubMedGoogle Scholar
  57. Meyer JS, Judd BW, Tawaklna T, Rogers RL, Mortel KF (1986) Improved cognition after control of risk factors for multi-infarct dementia. JAMA 256: 2203–2209CrossRefPubMedGoogle Scholar
  58. Meyer JS, Rogers RL, McClintic K, Mortel KF, Lotfi J (1989) Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study. J Am Geriatr Soc 37: 549–555PubMedGoogle Scholar
  59. Mielke R, Herholz K, Grond M, Kessler J, Heiss WD (1992) Severity of vascular dementia is related to volume of metabolically impaired tissue. Arch Neurol 49: 909–913CrossRefPubMedGoogle Scholar
  60. Moroney JT, Bagiella E, Desmond DW, Paik MC, Stern Y, Tatemichi TK (1996) Risk factors for incident dementia after stroke. Role of hypoxic and ischemic disorders. Stroke 27:1283–1289CrossRefPubMedGoogle Scholar
  61. Moroney JT, Bagiella E, Desmond DW et al (1997) Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology 49:1096–1105CrossRefPubMedGoogle Scholar
  62. Mortel KF, Meyer JS (1995) Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatr Clin Neurosci 7: 334–337Google Scholar
  63. Molsa PK, Marttila RJ, Rinne UK (1995) Long-term survival and predictors of mortality in Alzheimer’s disease and multi-infarct dementia. Acta Neurol Scand 91: 159–164CrossRefPubMedGoogle Scholar
  64. Pantoni L, Garcia JH (1995) The significance of cerebral white matter abnormalities 100 years after Binswanger’s report. A review [Review] [164 refs]. Stroke 26:1293–1301CrossRefPubMedGoogle Scholar
  65. Pantoni L, Lammie A (2002) Cerebral small vessel disease: pathological and pathophysiological aspects in relation to vascular cognitive impairment. In: Erkinjunti T, Gauthier S (eds) Vascular cognitive impairment. Martin Dunitz, LondonGoogle Scholar
  66. Pantoni L, Carosi M, Amigoni S, Mascalchi M, Inzitari D (1996) A preliminary open trial with nimodipine in patients with cognitive impairment and leukoaraiosis. Clin Neuropharmacol 19: 497–506CrossRefPubMedGoogle Scholar
  67. Pasquier F, Leys D (1997) Why are stroke patients prone to develop dementia? [Review] [94 refs]. J Neurol 244:135–142CrossRefPubMedGoogle Scholar
  68. Petersen RC (1995) Normal aging, mild cognitive impairment, and early Alzheimer’s disease. The Neurologist 1: 326–344Google Scholar
  69. Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M (1997) Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke 28: 785–792CrossRefPubMedGoogle Scholar
  70. Rocca WA, Hofman A, Brayne C et al (1991) The prevalence of vascular dementia in Europe: facts and fragments from 1980–1990 studies. EURODEM-Prevalence Research Group. Ann Neurol 30: 817–824CrossRefPubMedGoogle Scholar
  71. Rockwood K, Parhad I, Hachinski V et al (1994) Diagnosis of vascular dementia: Consortium of Canadian Centres for Clinical Cognitive Research concensus statement [Review] [60 refs]. Can J Neurol Sci 21: 358–364PubMedGoogle Scholar
  72. Rockwood K, Bowler J, Erkinjunti T, Hachinski V, Wallin A (1999) Subtypes of vascular dementia. Alzheimer Dis Assoc Disord 13: S59–S64PubMedGoogle Scholar
  73. Roman GC (1987) Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. JAMA 258:1782–1788CrossRefPubMedGoogle Scholar
  74. Roman GC, Tatemichi TK, Erkinjuntti T et al (1993) Vascular dementia: diagnostic criteria for reserach studies. Report of the NINDS-AIREN International Work Group. Neurology 43: 250–260CrossRefPubMedGoogle Scholar
  75. Rother M, Erkinjuntti T, Roessner M, Kittner B, Marcusson J, Karlsson I (1998) Propentofylline in the treatment of Alzheimer’s disease and vascular dementia. Dementia Geriatr Cogn Disord 9: 36–43CrossRefGoogle Scholar
  76. Skoog I (1997) Blood pressure and dementia. In: Hansson L, Birkenhager WH (eds) Handbook of hypertension, vol 18. Assessment of hypertensive organ damage. Elsevier Science BV, Amsterdam, pp 303–331Google Scholar
  77. Skoog I (1997b) The relationship between blood pressure and dementia: a review [Review] [139 refs]. Biomed Pharmacother 51: 367–375CrossRefPubMedGoogle Scholar
  78. Skoog I (1998) Status of risk factors for vascular dementia [Review] [89 refs]. Neuroepidemiology 17: 2–9CrossRefPubMedGoogle Scholar
  79. Skoog I, Nilsson L, Palmertz B, Andreasson L-A, Svanborg A (1993) A population-based study on dementia in 85-year-olds. N Engl J Med 328:153–158CrossRefPubMedGoogle Scholar
  80. Skoog I, Kalaria RN, Breteler MMB (1999) Vascular factors and Alzheimer’s disease. Alzheimer Dis Assoc Disord 13: S106–S114CrossRefPubMedGoogle Scholar
  81. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study [see comments]. JAMA 277: 813–817CrossRefPubMedGoogle Scholar
  82. Sulkava R, Erkinjuntti T (1987) Vascular dementia due to cardiac arrhythmias and systemic ypotension. Acta Neurol Scand 76:123–128CrossRefPubMedGoogle Scholar
  83. Suzuki K, Kutsuzawa T, Nakajima K, Hatano S (1991) Epidemiology of vascular dementia and stroke in Akita, Japan. In: Hartmann A, Kuchinsky W, Hoyer S (eds) Cerebral ischemia and dementia. Springer, New York, pp 16–24CrossRefGoogle Scholar
  84. Tatemichi TK (1990) How acute brain failure becomes chronic. A view of the echanisms and syndromes of dementia related to stroke. Neurology 40: 1652–1659CrossRefPubMedGoogle Scholar
  85. Tatemichi TK, Desmond DW, Mayeux R et al (1992) Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 42: 1185–1193CrossRefPubMedGoogle Scholar
  86. Tatemichi TK, Paik M, Bagiella E, Desmond DW, Pirro M, Hanzawa LK (1994) Dementia after stroke is a predictor of long-term survival. Stroke 25: 1915–1919CrossRefPubMedGoogle Scholar
  87. Tatemichi TK, Paik M, Bagiella E et al (1994) Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 44:1885–1891CrossRefPubMedGoogle Scholar
  88. Tomlinson BE, Blessed G, Roth M (1970) Observations on the brains of demented old people. J Neurol Sci 11: 205–242CrossRefPubMedGoogle Scholar
  89. Verhey FR, Lodder J, Rozendaal N, Jolles J (1996) Comparison of seven sets of criteria used for the diagnosis of vascular dementia. Neuroepidemiology 15:166–172CrossRefPubMedGoogle Scholar
  90. Wallin A, Blennow K (1994) The clinical diagnosis of vascular dementia [Review] [11 refs]. Dementia 5:181–184PubMedGoogle Scholar
  91. Wetterling T, Kanitz RD, Borgis KJ (1994) The ICD-10 criteria for vascular dementia. Dementia 5: 185–188PubMedGoogle Scholar
  92. Wetterling T, Kanitz RD, Borgis KJ (1996) Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 27: 30–36CrossRefPubMedGoogle Scholar
  93. World Health Organization (1993) ICD-10 Classification of mental and behavioural disorders: diagnostic criteria for research. WHO, GenevaGoogle Scholar

Copyright information

© Springer-Verlag Wien 2002

Authors and Affiliations

  • T. Erkinjuntti
    • 1
  1. 1.Memory Research Unit, Department of NeurologyUniversity of HelsinkiFinland

Personalised recommendations